Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Roxgold Inc. T.ROXG

Roxgold Inc is a Canadian gold mining company. It is engaged in acquiring and exploring mineral properties. The company has two reportable segments; Mining operations and Exploration and evaluation of mineral properties, located in Burkina Faso. Its key asset is the Yaramoko Gold Mine, located in the Hounde greenstone belt of Burkina Faso, West Africa, and Seguela Gold Project located in Cote d... see more

Recent & Breaking News (TSX:ROXG)

FDA Approves RITUXAN HYCELA (Rituximab and Hyaluronidase Human) for Subcutaneous Injection in Certain Blood Cancers

Business Wire June 22, 2017

Roche receives CE mark for CMV viral load testing on cobas® 4800 System

PR Newswire Europe Non Regulatory June 21, 2017

Eight International Companies Presented at the First Nasdaq International Designation Virtual Investor Conference

GlobeNewswire June 6, 2017

Roche receives FDA approval for CMV viral load testing on cobas® 6800/8800 Systems

PR Newswire June 5, 2017

APHINITY Study Shows Genentech’s Perjeta-Based Regimen Reduced the Risk of Invasive Cancer Returning Compared to Herceptin and Chemotherapy in HER2-Positive Early Breast Cancer

Business Wire June 5, 2017

Phase III Study Showed Genentech’s Alecensa (Alectinib) Reduced the Risk of Disease Progression or Death by More Than Half Versus Crizotinib as First-Line Treatment in a Specific Type of Lung Cancer

Business Wire June 5, 2017

Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients

PR Newswire June 1, 2017

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis

Business Wire May 22, 2017

Roxgold Reports Financial Results for Quarter Ended March 31, 2017

PR Newswire May 15, 2017

Roxgold Announces Results of Bagassi South Infill and Extensional Drilling Program

PR Newswire May 8, 2017

Roxgold Provides Notice of Release Date for its 2017 First Quarter Financial Results and Conference Call Details

PR Newswire May 1, 2017

Roxgold Inc. Opens the Market

Canada NewsWire April 13, 2017

Roxgold Graduates to the Toronto Stock Exchange and Changes Stock Symbol to ROXG

Canada NewsWire March 28, 2017

Roxgold provides notice of release date for its 2016 financials, 2017 first quarter operating results and 2016 reserve & resource statement

Canada NewsWire March 28, 2017

Roxgold Identifies New Shoot at Bagassi South Along the QV' Structure and Continues to Extend the 55 Zone at Depth

Canada NewsWire February 2, 2017

Roxgold Grants Stock Options and Performance Share Units

Canada NewsWire January 19, 2017

Breakthrough development for Americans with suspected heart attack - Next generation Troponin T test from Roche cleared by FDA

PR Newswire January 19, 2017

Roxgold's Yaramoko Gold Mine Passes Lenders' Completion Test and Amends Credit Facility

PR Newswire January 18, 2017

Roxgold announces production of 77,157 ounces of gold in 2016 and provides 2017 operational outlook

PR Newswire January 17, 2017

FDA Grants Genentech’s Cancer Immunotherapy TECENTRIQ® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer

Business Wire January 9, 2017